Ca. Harms et al., Correlation of transforming growth factor-beta messenger RNA (TGF-beta mRNA) expression with cellular immunoassays in triamcinolone-treated captive hybrid striped bass, J AQUAT A H, 12(1), 2000, pp. 9-17
Assessing fish immune status with molecular markers has been hampered by a
lack of specific reagents. A quantitative polymerase chain reaction (PCR) m
ethod (reverse transcription quantitative-competitive PCR, RT-qcPCR) for me
asuring transforming growth factor-beta (TGF-beta) transcription from a bro
ad range of teleost fish has recently been developed. The quantitative PCR
now permits monitoring production of this important immunosuppressive cytok
ine in response to immunomodulating agents and conditions. We examined ante
rior kidney and spleen mononuclear cells from hybrid striped bass (female s
triped bass Morone saxatilis x male white bass M. chrysops) for production
of TGF-beta messenger RNA (mRNA) in response to administration of the synth
etic glucocorticoid triamcinolone. We also compared TGF-beta transcription
with anterior kidney macrophage bactericidal activity and splenic lymphocyt
e blastogenesis. Anterior kidney mononuclear cell TGF-beta mRNA levels decr
eased, whereas bactericidal activity increased. Spleen TGF-beta mRNA levels
did not change significantly, and splenic lymphocyte pokeweed mitogen stim
ulation index increased in triamcinolone-treated fish. Since triamcinolone
is used therapeutically as a suppressive immunomodulator, the enhanced immu
ne functions indicated by the cellular immunoassays were unexpected; howeve
r, the inverse response of TGF-beta production and macrophage bactericidal
activity was consistent with the known relationship between TGF-beta and ma
crophage activation in mammals. Induced immunomodulation in hybrid striped
bass was detectable by both traditional cellular immunoassays and the new R
T-qcPCR for TGF-beta.